WDR13 and metabolic syndrome: WDR13 deletion in Leprdb/db mice improved adipose and pancreatic function which resulted in reduced dyslipidemia and hyperglycemia, two systemic factors contributing towards hepatosteatosis, leading to reduced serum triglycerol and free-fatty acids hence ameliorating the fatty liver phenotype.